To learn more, please feel free to contact us by
WhatsApp: +86-15913221631
Assayed hematology control for evaluating the precision of analyzers with 3- and 5-part
differential technology.
The various cell particles included in Hematology Control have similar properties to WBC, RBC, and PLT in human blood. When tested on a blood cell analyzer, they can accurately simulate human blood.Monitor the status of the analyzer. The quality control materials also contain preservation reagents and preservative reagents, which can stabilize the properties of various cell simulation particles and enable the quality control materials to be stored stably for more than several months.
Hematology Control is an assayed whole blood control designed to monitor values on multi-parameter hematology cell counters.
The use of quality control materials is indicated as an objective assessment of the precision of methods and techniques in use and is an integral part of good laboratory practices. Three（Low, Normal, High) levels of control are available to allow performance monitoring within the clinical range on).
Notice:a.This product will be stable until the expiration date when stored unopened at 2 to 8°C.
b.Once opened, this product will be stable for 7 days when handled properly and stored tightly capped at 2 to 8°C.
c.Protect tubes from OVERHEATING and FREEZING.
d.Store product upright when not in use.
e.This product is shipped under refrigerated conditions.
Specifications
High Level 2ml x 2
Normal Level 2ml x 2
Low Level 2ml x 2
Content And Storage 2°C to 8°C
Extensive Clinical Experience
- For PRP with separation gel, Longtime is the only made-in-China supplier who can provide for public hospitals in China. - Longtime PRP has covered more than 1500 users and is currently only available for domestic public hospitals.
- Now we are honestly recruiting OEM cooperated partners or distributor from all over the world.
Zhuhai Longtime Biological Technology Co., LTD.
Longtime Bio. has been based in the field of regenerative medicine for many years, with innovative regenerative medicine technologies such as PRP(Platelet-Rich Plasma), stem cells, exosomes, and cellular immunotherapy as its business direction. It has excellent scientific research, management, production, registration teams, and professional international high-level. The team of medical experts mainly provides clinical products and technologies such as Platelet-Rich Plasma (PRP) preparation device, Mononuclear Cell Preparation Tubes (CPT), Micro-column Gel Blood Grouping Card technology for diagnosis and treatment.
Oversea Exhibition:
- FIME 2024, Jun 19~21, Miami, USA. (Will come soon)
- Arab Health 2024, Jan 29~Feb 1, Dubai, U.A.E.
- Russian Health Care 2023, Dec 4~8, Mosscow (ZDRAVOOKHRANENIYE)
- Medica 2023, Nov 13~16, Düsseldorf, Germany.
- Asia Health 2023, Aug 16~18, Bangkok, Thailand
- FIME 2023, Jun 21~23, Miami, USA.
- EuroTier 2022, Nov 15~18, Hanover, Germany.
- Arab Health 2020, Jan 27th-30th, Dubai, U.A.E.
- Medica 2019, Nov18th-20th, Düsseldorf, Germany.
){kind=link}